Polynucleotide vaccines: potential for inducing immunity in animals

被引:8
作者
Babiuk, LA
Lewis, J
Suradhat, S
Baca-Estrada, M
Foldvari, M
Babiuk, S
机构
[1] VIDO, Saskatoon, SK S7N 5E3, Canada
[2] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK, Canada
关键词
polynucleotide vaccines; immunization; animals;
D O I
10.1016/S0168-1656(99)00116-9
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Polynucleotide immunization has been described as the Third Revolution in Vaccinology. Early studies suggest the potential benefits of this form of immunization including: long-lived immunity, a broad-spectrum of immune responses (both cell mediated immunity, and humoral responses) and the simultaneous induction of immunity to a variety of pathogens through the use of multivalent vaccines. Using a murine model, we studied methods to enhance and direct the immune response to polynucleotide vaccines. We demonstrated the ability to modulate the magnitude and direction of the immune response by co-administration of plasmid encoded cytokines and antigen. Also, we clearly demonstrated that the cellular components (cytosolic, membrane-anchored, or extracellular) to which the expressed antigen is delivered determines the types of immune responses induced. Since induction of immunity at mucosal surfaces (route of entry for many pathogens) is critical to prevent infection, various methods of delivering polynucleotide vaccines to mucosal surfaces have been attempted and are described. Expansion of studies in various species, using natural models, should be extremely helpful in demonstrating the universality of this approach to immunization and more importantly, accurately identify parameters that are critical for the development of protective immunity. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:131 / 140
页数:10
相关论文
共 61 条
[1]   Potential of particulate carriers for the mucosal delivery of DNA vaccines [J].
Alpar, HO ;
Ozsoy, Y ;
Bowen, J ;
Eyles, JE ;
Conway, BR ;
Williamson, ED .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1997, 25 (02) :S337-S337
[2]   DNA immunization with bovine herpesvirus-1 genes [J].
Babiuk, LA ;
Lewis, PJ ;
Cox, G ;
LittelvandenHurk, SV ;
BacaEstrada, M ;
Tikoo, SK .
DNA VACCINES: A NEW ERA IN VACCINOLOGY, 1995, 772 :47-63
[3]   Immunization with plasmid DNA encoding for the measles virus hemagglutinin and nucleoprotein leads to humoral and cell-mediated immunity [J].
Cardoso, AI ;
BlixenkroneMoller, M ;
Fayolle, J ;
Liu, M ;
Buckland, R ;
Wild, TF .
VIROLOGY, 1996, 225 (02) :293-299
[4]   Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2 [J].
Chow, YH ;
Huang, WL ;
Chi, WK ;
Chu, YD ;
Tao, MH .
JOURNAL OF VIROLOGY, 1997, 71 (01) :169-178
[5]  
COMPANS RW, 1996, P 5 ROT WORKSH CURR
[6]   DNA-based immunization by in vivo transfection of dendritic cells [J].
Condon, C ;
Watkins, SC ;
Celluzzi, CM ;
Thompson, K ;
Falo, LD .
NATURE MEDICINE, 1996, 2 (10) :1122-1128
[7]  
Conry RM, 1996, GENE THER, V3, P67
[8]   DNA-BASED IMMUNIZATION INDUCES CONTINUOUS SECRETION OF HEPATITIS-B SURFACE-ANTIGEN AND HIGH-LEVELS OF CIRCULATING ANTIBODY [J].
DAVIS, HL ;
MICHEL, ML ;
WHALEN, RG .
HUMAN MOLECULAR GENETICS, 1993, 2 (11) :1847-1851
[9]   Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA [J].
Davis, HL ;
Millan, CLB ;
Watkins, SC .
GENE THERAPY, 1997, 4 (03) :181-188
[10]  
DEBS RJ, 1995, LIPOSOMES TOOLS BASI, P171